Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Nyxoid 1.8 mg nasal spray, solution in a single-dose container

Active Ingredient:
naloxone hydrochloride dihydrate
Company:  
Napp Pharmaceuticals Limited See contact details
ATC code: 
V03AB15
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Nyxoid - Healthcare Professional Guidance Document

{healthcare_pro_orange} For Healthcare Professionals
To provide brief information for HCPs on Nyxoid
{pdf_link}

Nyxoid - Training Card

Training Card for Patients and Carers
{pdf_link}

Nyxoid Patient Information Card

Information on: How to recognise symptoms of an opioid overdose, What to do, How to give Nyxoid and How to recognise acute withdrawal symptoms

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Napp Pharmaceuticals Limited
Company image
Address
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone
+44 (0)1223 424 444
WWW
http://www.napp.co.uk
Medical Information e-mail
[email protected]